Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_assertion type Assertion NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_head.
- NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_assertion description "[Finally, daily chronic administration of RSVl alleviated hypertension in the experimental model of AngII-induced hypertensive mice, and these effects were accompanied by the activation of AMPK, significantly decreased RhoA activity and phosphorylation levels of MYPT1 and MLC in AngII-treated murine aortic VSMCs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_provenance.
- NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_assertion evidence source_evidence_curated NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_provenance.
- NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_assertion SIO_000772 24965170 NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_provenance.
- NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_assertion wasDerivedFrom ctd_human-20150221 NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_provenance.
- NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_assertion wasGeneratedBy ECO_0000218 NP6197.RA_LaOCPnKUXFmx8_ypu2MV1WfHo9RK3u32NI4ZF7Kmiw130_provenance.